Hypopituitarism and atherosclerosis

Annals of Medicine

Volumn 33, Issue 7, 2001, Pages 477-485

  Elhadd, T A ^a   Abdu, T A M ^a   Clayton, R ^a  

^a KEELE UNIVERSITY   (United Kingdom)

Author keywords

Atherosclerosis; Endothelial dysfunction; Growth hormone deficiency; Hypopituitarism; Insulin resistance

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ANTIOXIDANT; BIOLOGICAL MARKER; CORTISONE ACETATE; ESTROGEN; GROWTH HORMONE; HYDROCORTISONE; METFORMIN; SEX HORMONE; THYROID HORMONE;

ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING DISORDER; BRAIN RADIATION; DRUG EFFECT; EPIDEMIOLOGICAL DATA; FIBRINOLYSIS; GLUCOSE METABOLISM; GROWTH HORMONE DEFICIENCY; HEART DISEASE; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; HYPOPITUITARISM; INSULIN RESISTANCE; LIPID METABOLISM; MORTALITY; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; SEX DIFFERENCE; VASCULAR ENDOTHELIUM;

EID: 0034785990     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853890109002097     Document Type: Article

References (83)

1. Premature mortality due to cardiovascular disease in hypopituitarism
2. Increased cerebrovascular mortality in patients with hypopituitarism
3. The effect of hypopituitarism on life expectancy
4. Life expectancy following surgery for pituitary tumours
5. Premature mortality in 1014 patients with hypopituitarism
6. Coronary risk in growth hormone deficient adults: Increased predicted risk largely due to lipid profile abnormalities
7. The pathogenesis of atherosclerosis: A perspective for the 1990s
8. Abnormal markers of endothelial cell activation and oxidative stress in children, adolescents and young adults with Type-1 diabetes mellitus in the absence of clinical vascular disease
9. Diabetes and endothelial dysfunction: A clinical perspective
10. Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the atherosclerosis risk in Communities (ARIC) Study: A case cohort study
11. Cigarette smoking increases white blood cell aggregation in whole blood
12. Soluble cell adhesion molecules in hypertriglyceridaemia and potential significance on monocyte adhesion
13. Growth hormone treatment (GH) reverses early atherosclerotic changes in GH-deficient adults
14. Relationship between biochemical and biophysical markers of endothelial dysfunction in adults with growth hormone deficiency: The missing link between hypopituitarism and reduced life expectancy?
15. Nitric oxide may mediate the haemodynamics effects of recombinant growth hormone in patients with acquired growth hormone deficiency
16. Endothelial dysfunction in hypopituitary adults with growth hormone deficiency
17. Increase of adhesion molecules, fibrinogen, plasminogen activator inhibitor and orosomucoid in growth hormone (GH) deficient adults and its modulation by recombinant human GH replacement
18. Circulating adhesion molecules VCAM-1, ICAM-1 and E-selectin in carotid atherosclerosis and incident coronary heart disease patients: The Atheroscleosis Risk In Community study (ARIC)
19. Von Willebrand factor and factor VIII: C in acute cerebrovascular disease. Relationship to stroke subtypes and mortality
20. Elevated thrombomodulin and vascular endothelial growth factor in juvenile Typed-1 diabetic patients
21. Use of ultrasonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study
22. Ultrasound B-mode imaging in observational studies of atherosclerosis progression
23. Detection of premature atherosclerosis by high resolution ultrasonography in symptom free hypopituitary adults
24. Increased arterial intima-media thickness in childhood-onset growth hormone deficiency
25. High fibrinogen and plasminogen activator inhibitor activity in growth hormone deficient adults
26. Cardiac structural and functional abnormalities in adults patients with growth hormone deficiency
27. Myocardial dysfucntion in treated adults with hypopituitarism: A possible explanation for increased cardiovascular mortality
28. Increased prevalence of osteoporosis and arteriosclerosis in conventionally substituted anterior pituitary insufficiency: Need for additional growth hormone substitution?
29. Growth hormone treatment improves serum lipids and lipoprotein in adult patients with growth hormone deficiency
30. Cardiovascular risk factors in adult patients with growth hormone deficiency
31. Metabolic abnormalities in growth hormone deficient adults. II. Carbohydrate tolerance and lipid metabolism
32. Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy
33. Serum lipids in growth hormone deficient men
34. Insulin action
35. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults
36. Obesity associated insulin resistance occurs in hypopituitary men
37. Beta-cell function in hypopituitary adults before and after growth hormone treatment
38. Interaction of body fat and muscle mass with substrate concentration and fasting insulin levels in adults with growth hormone deficiency
39. Body composition in growth hormone deficient adults
40. Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency
41. Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults
42. Adipose tissue assessed by magnetic resonance imaging in growth hormone deficient adults: The effects of growth hormone replacement and a comparison with control subjects
43. Distribution of adipose tissue and risk of cardiovascular disease and death: A 12 year follow up of participants in the population study of Gotenburg, Sweden
44. Abdominal adipose tissue distribution, obesity and risk of cardiovascular disease and death: 13 Year follow up of participants in the study of men born in 1913
45. Relationship of body fat distribution to metabolic complications of obesity
46. Role of obesity and fat distribution in non-insulin dependent diabetes mellitus in Mexican-Americans and non-Hispanic whites
47. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance
48. Relationship between insulin resistance, soluble adhesion molecules and mononuclear cell binding in healthy volunteers
49. Glucose and lipid haemostasis in the absence of growth hormone
50. Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency
51. Alteration of monocyte function in patients with growth hormone deficiency: Effect of substitutive GH therapy
52. Growth hormone replacement therapy in adults with growth hormone deficiency improves vascular reactivity
53. The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency
54. The effects of growth hormone on serum lipids lipoproteins, apoproteins and cholesterol precursors in adults growth hormone deficient patients
55. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone deficient adults
56. Insulin, insulin-like growth factors, and vascular endothelium
57. Identification and characterization of insulin-like growth factor receptor on adult rat cardiac myocytes: Linkage to inositol
58. Nitric oxide inhibitor prevents vasodilatation by insulin-like growth factor 1
59. Direct demonstration of insulin-like growth factor-1 induced nitric oxide production by endothelial cells
60. Inhibitory effect of octreotide on growth hormone-induced IGF-1 generation and organ growth in hypophysectomized rats
61. An assessment of optimal hydrocortisone replacement therapy
62. Glucocorticoid replacement therapy: Are patients overtreated and does it matter?
63. Carbohydrate metabolism in hypercortisolism
64. Cushing's syndrome
65. The assessment of glucocorticoid replacement therapy
66. Hormone replacement therapy and cardiovascular risk: The 'cardiovascular physicians' viewpoint
67. Sex hormone and vascular reactivity
68. Oestrogen replacement reverses endothelial dysfunction in postmenopausal women
69. Short-term eostrogen augments both nitric oxide-mediated and no-nitric oxide mediated endothelium dependent forearm vasodilatation in post-menopausal women
70. Modulation of endothelial-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle
71. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: Implications for atherosclerosis
72. Preclinical hypothyroidism: A risk factor for coronary heart disease
73. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The Rotterdam Study
74. Increased free radical release in hypopituitary adults with GHD
75. The incidence of cerebrovascular accidents in patients with pituitary adenoma
76. Incidence of cerebral infarction after radiotherapy for pituitary adenoma
77. The effect of radiation on carotid arteries
78. Stroke after pituitary irradiation
79. Progressive cerebral occlusive disease after radiation therapy
80. Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity
81. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review
82. Cardiovascular disease and risk factors in adults with hypopituitarism